Idorsia Ltd
SIX:IDIA
Idorsia Ltd
Total Current Liabilities
Idorsia Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Idorsia Ltd
SIX:IDIA
|
Total Current Liabilities
CHf160.9m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Total Current Liabilities
$70.2m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Total Current Liabilities
$149.1m
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
31%
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Total Current Liabilities
CHf49.2m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-3%
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Total Current Liabilities
CHf27m
|
CAGR 3-Years
27%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
|
Relief Therapeutics Holding SA
SIX:RLF
|
Total Current Liabilities
CHf3.8m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
Glance View
Idorsia Ltd. operates as a biopharmaceutical firm which focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2017-06-16. The firm will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The firm's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.
See Also
What is Idorsia Ltd's Total Current Liabilities?
Total Current Liabilities
160.9m
CHF
Based on the financial report for Dec 31, 2025, Idorsia Ltd's Total Current Liabilities amounts to 160.9m CHF.
What is Idorsia Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 3Y
-2%
Over the last year, the Total Current Liabilities growth was -64%. The average annual Total Current Liabilities growth rates for Idorsia Ltd have been -2% over the past three years .
